Insider Trading & Ownership - Liu David Y

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Liu David Y
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-17
Sale
2021-08-19
5:49 pm
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
14,779$47.56$702,88972,021
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-16
Exercise
2022-11-17
6:24 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief R&D Strategy Officer
15,725$1.89167,590
(Direct)
View
2022-11-16
Exercise
2022-11-17
6:24 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief R&D Strategy Officer
35,656$1.16167,590
(Direct)
View
2022-11-16
Exercise
2022-11-17
6:24 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief R&D Strategy Officer
35,331$4.21167,590
(Direct)
View
2022-11-16
Exercise
2022-11-17
6:24 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief R&D Strategy Officer
13,767$0.87167,590
(Direct)
View
2022-11-16
Exercise
2022-11-17
6:24 pm
N/A
2023-09-26
Protagonist Therapeutics IncPTGXLiu David Y
Chief R&D Strategy Officer
100,479$0167,590
(Direct)
View
2022-02-28
Tax Withholding
2022-03-02
8:38 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
2,119$24.2866,538
(Direct)
View
2022-02-15
Option Award
2022-02-17
7:25 pm
N/A
2032-02-14
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
70,000$0128,657
(Direct)
View
2021-08-17
Exercise
2021-08-19
5:49 pm
N/A
N/A
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
10,000$0.8772,021
(Direct)
View
2021-08-17
Exercise
2021-08-19
5:49 pm
N/A
2023-09-26
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
10,000$072,021
(Direct)
View
2021-02-26
Option Award
2021-02-26
6:31 pm
N/A
2031-02-25
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
75,000$0127,427
(Direct)
View
2020-02-28
Option Award
2020-02-28
5:46 pm
N/A
2030-02-27
Protagonist Therapeutics IncPTGXLiu David Y
Chief Scientific Officer
70,000$070,000
(Direct)
View